Novonesis (Novozymes) B/ DK0060336014 /
04/10/2024 15:07:38 | Chg. -6.30 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
465.30DKK | -1.34% | 18,741 Turnover: 8.74 mill. |
-Bid Size: - | -Ask Size: - | 129.56 bill.DKK | 0.90% | 42.78 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 10.92 DKK | -17.83% |
EPS Diluted: | - DKK | -17.51% |
Revenues per Share: | 64.54 DKK | 2.49% |
Book Value per Share: | 50.40 DKK | 1.54% |
Cash Flow per Share: | 14.97 DKK | 4.17% |
Dividend per Share: | 4.20 DKK | -30.00% |
Total | in mill. | |
Revenues: | 17,899.00 DKK | 1.97% |
Net Income: | 3,024.00 DKK | -17.96% |
Operating Cash Flow: | 4,152.00 DKK | - |
Cash and Cash Equivalents: | 1,116.00 DKK | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 42.78 | 33.98 |
P/S Ratio: | 7.24 | 5.75 |
P/BV ratio: | 9.27 | 7.36 |
P/CF Ratio: | 31.20 | 24.79 |
PEG: | -2.40 | -1.91 |
Earnings Yield: | 2.34% | 2.94% |
Dividend Yield: | 0.90% | 1.13% |
Market Capitalization | ||
Market Capitalization: | 129.56 bill. DKK | 102.91 bill. DKK |
Free Float Market Cap.: | - DKK | - DKK |
Market Cap. / Employee: | 19.18 mill. DKK | 15.23 mill. DKK |
Shares Outstanding: | 277.32 mill. |
Profitability
Gross Profit Margin: | 54.32% |
EBIT Margin: | 22.21% |
Net Profit Margin: | 16.89% |
Return on Equity: | 21.63% |
Return on Assets: | 10.65% |
Financial Strength
Liquidity I / Cash Ratio: | 15.37% |
Liquidity II / Quick Ratio: | 66.35% |
Liquidity III / Current Ratio: | 130.29% |
Debt / Equity Ratio: | 103.11% |
Dynam. Debt / Equity Ratio: | 347.13% |
Efficiency
Employees: | 6,756 |
Personal Expenses / Employee: | - DKK |
Revenues / Employee: | 2,649,348.73 DKK |
Net Income / Employee: | 447,602.13 DKK |
Total Assets / Employee: | 4,202,338.66 DKK |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | IFRS |
Currency: | DKK |